Regulatory News

April 6, 2018 / 6:28 AM / 2 months ago

BRIEF-Shield Therapeutics Says It Plans To Submit NDA For Feraccru

Reuters Staff

1 Min Read

April 6 (Reuters) - Shield Therapeutics PLC:

* SUBMISSION MEETING WITH FDA

* CONFIRMS PLANS TO SUBMIT A NEW DRUG APPLICATION FOR FERACCRU® AS SOON AS POSSIBLE

* NEW DRUG APPLICATION (NDA) SUBMISSION MEETING Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below